trial · primary record
Pfizer-BioNTech mRNA COVID-19 vaccine
Stage 4 NSCLC
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2035-03 |
| Primary endpoint | Incidence of immune-related adverse events requiring hospitalization |
| Registry ID | NCT07597070 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:44.625Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07597070
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.